A panel of 11 monoclonal antibodies (MAbs) raised against pseudorabies virus (PRV) was used to map epitopes on the virus glycoprotein I (gI). We employed three approaches to map epitopes on gI. By a competition binding assay, six groups of MAbs were defined as reacting with distinct antigenic domains on gI. To identify regions along the gI polypeptide chain encompassing the domains recognized by these MAbs, DNA fragments derived from the gI-coding region were cloned into pEX expression plasmids. The antigenic reactivity of the fusion proteins expressed in Escherichia coil was analysed by immunoblotting. Five antigenic domains were mapped within the first 238 amino acids of gI: domains A, B and D were mapped between amino acids 52 and 123 and domains C and E between amino acids 78 and 238. One MAb, representing domain F, did not react with the expressed fusion proteins. To assess the precise location and amino acid sequences of the epitopes, overlapping nonapeptides covering the amino acid sequence 52 to 238 were synthesized. The antibody-binding activity of these peptides was tested by an ELISA (Pepscan-method). Three antigenic domains were mapped: domain A was localized to amino acids 64 to 73 and 75 to 84, domain B to amino acids 52 to 67 and domain D to amino acids 68 to 82. Four MAbs representing antigenic domains C, E and F did not react in the Pepscan. Finally, sera from pigs infected experimentally with PRV reacted with the fusion protein ofplasmid psi (amino acids 52 to 238).
Introduction
Aujeszky's disease is economically one of the most important diseases of today's pig industry. The disease is caused by psuedorabies virus (PRV), a member of the Alphaherpesvirinae. Pigs are vaccinated to reduce economic losses. However vaccination generally does not prevent infection and establishment of latency, and therefore will not lead to the eradication of PRV (Van Oirschot & Gielkens, 1984) . Therefore tests to differentiate between infected and vaccinated pigs are crucial for the control of PRV in countries where vaccination is widely practised. For that purpose ELISA techniques have been developed that are based on detection of antibodies to glycoprotein I (gI) of PRV (Van Oirschot et al., 1986 Eloit et al., 1989) . The gI of PRV is expressed by all wild-type virus strains tested so far (Van Oirschot, 1989) , whereas some vaccine virus strains and genetically engineered deletion mutants lack gI (Hampl et al., 1984; Mettenleiter et aL, 1985a; Gielkens et al., 1989) . Programmes to control Aujeszky's disease will be based on the use of either gI-negative, glII-negative (Kit et al., 1987) or gX-negative vaccines (Marchioli et al., 1987) , the identification of infected pigs by detection of antibodies to gI and the removal of these infected pigs from the herds. To investigate the gI-specific immune response in pigs, we characterized and localized epitopes 0000-9286 © 1990 SGM on gI by a competitive ELISA, by immunoscreening parts of the gI sequence expressed in a prokaryotic expression system and by the Pepscan method (Geysen et al., 1984 (Geysen et al., , 1985 .
Methods
Monoclonal antibodies (MAbs) . MAbs were produced against PRV strains NIA-3 and Phylaxia, and were purified from ascites fluid by ammonium sulphate precipitation and diluted in phosphate-buffered saline (PBS) to a final protein concentration of approximately 7 mg/ml. MAbs were conjugated to horseradish peroxidase (HRPO), essentially as described by Wilson & Nakane (1978) .
Competitive ELISA. ELISA plates from Behringwerke, coated with PRV antigen (Enzygnost Aujeszky) were used. Serial dilutions of MAbs-HRPO conjugates in PBS containing 0.05~ Tween 80 were made to determine the highest dilution of conjugate yielding an absorbance at 450 nm (Aa5o) of 1.5 to 2.0 in the absence of a second unlabelled antibody. Twice that concentration of conjugate was used in the competition ELISA. Each of the competing unconjugated MAbs was diluted 1:50, 1:100 and 1:1000, in each of the MAb--HRPO dilutions. The mixtures were transferred to the wells of the ELISA plate (100 gl/well). After incubation for 1 h at 37 °C the plates were washed with 0.05~ Tween in deionized water and 100 p.1 of the substrate 3,Y,5,5-tetramethylbenzidine (1 mg/ml) was added. The reactions were stopped by adding 100 gl of 0-5 M-H2SO4 and the plates were read at 450 nm in a Titertek multiscan plate reader. The A45o value in wells without competing antibody was set at 100%. When a MAb dilution decreased the A45o value of the conjugated MAb by > 50~ it was considered to show competition.
Recombinant DNA techniques. Unless mentioned otherwise, the recombinant DNA techniques were done essentially as described by Maniatis et al. (1982) or Davis et al. (1986) . Restriction enzymes and DNA-modifying enzymes were used as described by the manufacturer. Plasmid DNA was prepared using the alkaline lysis method (Maniatis et al., 1982) . DNA restriction fragments were isolated from agarose gels by electroelution (Bio Trap, Schleicher & SchiiU) .
Construction of recombinant plasmids expressing gl. The pEX plasmid expresses inserted genes as a cro-fl-galactosidase fusion protein. Expression of this gene is under control of the 2 Pr promoter and is induced by inactivation of the temperature-sensitive cI repressor at 42 °C (Stanley, 1983; Stanley & Luzio, 1984 . We transformed Escherichia eoli strain pop 2136 (constructed by Dr Rabaud, Institut Pasteur, Paris) by the CaC12 transformation procedure. Transformation occurred after a heat shock of 5 min at 34 °C and 2 rain on ice. Plasmids linearized by a single digestion were dephosphorylated with calf intestinal phosphatase. The AhalII/NruI fragment (2055 bp isolated from BamHI-7 fragment of PRV strain NIA-3; Quint et al., 1987) with the entire gI coding sequence and fragments derived from the gI-coding region, were cloned in the correct reading frame into the Sinai site of pEX1, pEX2 or pEX3. Fragments were made blunt if necessary by treatment with the Klenow fragment of DNA polymerase I.
Isolation of expression products. Expression of the pEX fusion proteins was induced by incubation of a 1.5 ml exponentially growing culture (optical density at 600 nm of approximately 0.25) of cells at 42 °C for 90 min. The expression products were purified as follows: cells were spun down (5 rain at 6000 g), resuspended in 100 p.l 50 mMTris-HC1 pH 8.0, 50 m~-EDTA, 15~ (w/v) sucrose and treated with lysozyme (1 mg/ml) for 10 min. After addition of 140 lal of 0.2~ (w/v) Triton X-100 in 10 mM-Tris-HC1 pH 8, DNA was degraded by adding 24 ~tl 1 M-MgCI2 and 1 ~tl DNase (10 mg/ml). Incubation was at 37 °C until the suspension was no longer viscous. After spinning down the insoluble expression proteins, we resuspended the pellet in 250/d of PBS.
Immunoscreening of expression products. A 5 ~tl sample of resuspended proteins was dissolved in lysis buffer (10 mM-Tris-HC1 pH 8-0, 1 mM-EDTA, 10% glycerol, 2% SDS, 5% 2-mercaptoethanol; Laemmli, 1970) . The proteins were fractionated by 7-5% SDS-PAGE, followed by Western blotting, using the LKB Multiphor II Nova Blot system in 40 mM-glycine, 50 mM-Tris, 0.04% SDS (w/v) and 20% methanol (v/v). The nitrocellulose sheets (BA-85, Schleicher & Schfill) were washed twice in PBS containing 0.5% (w/v) gelatin, 0.1% (w/v) Triton X-100 (PBS-GT) incubated for 1 h at room temperature with antibodies (MAb diluted 1 : 1000 in PBS-GT). The filters were washed three times for 5 min in PBS-GT and incubated with rabbit anti-mouse IgG-HRPO conjugate for 1 h at room temperature. The filters were washed three times for 5 min in PBS-GT and once for 5 min in PBS and incubated in substrate solution [3'-3'-diaminobenzidine (0.5 mg/ml) and 0.001~ HzO2] for about 5 min.
Sera were from specified pathogen-free pigs infected intranasally with 103 p.f.u, of the PRV strain Sterksel or NIA-3, or from a pig vaccinated twice with a gI-negative vaccine (Auskimune). Sera were collected 11 weeks post-infection (p.i.). Pig sera were tested in a dilution of 1:200.
Pepscan. Overlapping nonapeptides starting from amino acid 52 through to 238 of the gI protein were synthesized and tested as described (Geysen et al., 1984 (Geysen et al., , 1985 . The amino acid sequence employed was based on the sequence of PRV strain Rice (Petrovskis et al., 1986 ). All MAbs were tested at a 1 : 150 dilution in an ELISA as described by Geysen et al. (1984 Geysen et al. ( , 1985 .
Results

Topographical analysis of the gI antigenic domains by a competitive ELISA
The gI specificity of the MAbs was determined by a radioimmunoprecipitation assay and SDS-PAGE (data not shown). In the competitive ELISA all MAbs inhibited the binding of the homologous MAb-HRPO by more than 50~ (Fig. 1) between MAbs 4 and 1 at a 1:50 dilution, and MAbs 3 and 4 competed in a non-reciprocal fashion at 1:50 dilution only.
Localization of antigenic domains by binding of gI-specific MAbs to gI-containing fusion proteins
An AhaIII/NruI fragment containing the entire gIcoding region was cloned in the proper reading flame into the pEX2 plasmid (plasmid pl encoding 685 amino acids; Fig. 2 ). In the pEX expression system foreign gene fragments are inserted at the 3' end of the cro-lacZ gene, resulting in a hybrid protein of I15K (cro-/~-galactosidase) plus the product of the foreign gene. The predicted size of the expression protein of plasmid pl is 115K plus 80K (Mettenleiter et al., 1985b) . Analysis of the hybrid protein by SDS-PAGE revealed a protein band of about 190K (Fig. 3) . In a Western blot 10 out of 11 MAbs tested recognized this protein (Table 1) .
To map the antigenic domains on the protein the AhalII/NruI fragment was digested with NaeI and, depending on the desired reading frame, the fragments were cloned into the SmaI site of pEX1, pEX2 or pEX3, resulting in the plasmids p2 (amino acids 52 to 305), p3 (amino acids 501 to 654), p4 (amino acids 305 to 411), p5 (amino acids 411 to 501) and p6 (amino acids -15 to 52).
Only the fusion protein of plasmid p2 was recognized by the same MAbs which bound to the fusion protein of plasmid pl (containing the entire gI coding sequence). 
. Jacobs and others
These results indicate that the antigenic domains A, B, C, D and E were localized between amino acids 52 and 305. Subsequently fragments derived from the gI-coding DNA sequence of p2 were cloned into pEX (Fig. 2) . In a Western blot the 10 MAbs which recognized the fusion proteins of the plasmids p 1 and p2, reacted also with the fusion proteins of the plasmid psi (amino acids 52 to 238). MAbs 1, 3 and 5 (domain A), MAbs 4, 8 and 11 (domain B) and MAb 7 (domain D) reacted with the fusion proteins of the plasmid ps4 (amino acids 52 to 123) and not with the fusion proteins of the plasmids ps2 (amino acids 78 to 238) and ps3 (amino acids 123 to 238). MAb 2 (domain E) and MAbs 6 and 9 (domain C) reacted only with the fusion protein of plasmid ps2. These findings indicate that the antigenic domains A, B and D were localized between amino acid residues 52 to 123, probably between amino acid residues 52 to 78, and that the antigenic domains C and E were localized between amino acid residues 78 to 238. The fusion protein of plasmid ps3 was not recognized by any of the gI-specific MAbs tested (Table 1 ). The reactions of two MAbs in the Western blot are shown in Fig. 3 .
Localization of the epitopes by the Pepscan method
Overlapping nonapeptides (187) spanning the psi plasmid product (amino acids 52 to 238) were tested by Pepscan with the gI-specific MAbs. MAbs 1, 3 and 5 (antigenic domain A) reacted with peptides within the amino acid sequences 64 to 73 and 75 to 84. MAbs 4, 8 and 11 (domain B) reacted with peptides within the amino acid sequence 52 to 67. MAb 7 (domain D) recognized peptides within the amino acid sequence 68 to 82 (Fig. 4b) . The reaction patterns of MAbs 1, 3 and 5 with all nonapeptides were similar as were the reaction patterns found for MAbs 4, 8 and 11. The MAbs 2, 6, 9 and 10 representing the antigenic domains C, E and F did not react with any of the synthesized peptides (Fig.  4a) .
Reactivity of pig sera with the fusion protein of plasmid psi
To investigate whether pigs produce antibodies against the antigenic domains determined by analysis with murine MAbs, the fusion proteins of plasmid psi (amino acids 52 to 238) and the pEX plasmid without insertions were tested in a Western blot analysis with sera of PRVinfected pigs and pigs vaccinated with a gI-negative live vaccine. The reactions of the pig sera in the Western blot are shown in Fig. 5 . All sera from infected pigs reacted with the fusion protein from plasmid psi, but not with the expressed protein of the pEX plasmid without the insert. The serum of the pig vaccinated twice with a gInegative vaccine did not react with the fusion protein encoded by psi.
Discussion
Tests for the detection of antibodies to gI are crucial for the eradication of Aujeszky's disease in the future (Van Oirschot et al., 1986 Van Oirschot, 1989 ; Eloit et al., 1989). For the development of an optimal detection system for gI-specific antibodies in pigs, knowledge about the epitopes on gI is necessary. The competitive ELISA revealed the presence of six antigenic domains when a 1 : 1000 dilution of competing MAb was taken as a criterion. However, at a 1:50 dilution of competing MAbs the competitive ELISA revealed five domains. Antigenic domain D was then incorporated into the domain A; these two domains appear to be closely linked.
Indeed, the Pepscan analysis showed that these antigenic domains were overlapping (Fig. 4) . The Pepscan showed also that domain B partly overlapped domain A. However the most important amino acids necessary for binding of the MAb to the peptides did not overlap (see Fig. 4b , boxed amino acids). In the competitive ELISA, the overlap resulted in only a weak competition of MAb 4 with MAbs 1 and 3.
Several MAbs did not compete reciprocally. Nonreciprocal competition may be explained by differences in affinity of the two MAbs, or by a conformational change induced by binding of one MAb that alters the binding of the other (Getzoffet al., 1987) . We also cannot exclude that the conjugating of a MAb to the enzyme alters its binding capacity.
By expression of subgenomic fragments in a prokaryotic expression system, 2gtll or pEX for example (Nunberg et al., 1984; Mehra et al., 1986; Luytjes et al., 1989; Lenstra et al., 1989) , it is possible to localize antigenic domains on proteins. We have chosen to express relatively large subgenomic fragments in pEX to localize domains roughly and to use the Pepscan analysis to localize a number of epitopes precisely (Middeldorp & Meloen, 1988) .
By the immunoscreening of fusion proteins in a Western blot it was possible to localize the antigenic domains A, B and D within the amino acid sequence 52 to 123 and domains E and C within amino acid sequence 78 to 238 at the N-terminal end of the gI protein.
Localization of the epitopes at the N-terminal end of the protein is not unexpected because the C-terminal end of the gI protein contained the membrane anchor sequence (amino acids 429 to 453) and a hydrophilic region (amino acids 453 to 577) probably in contact with the interior of the virion (Petrovskis et al., 1986) .
None of the 11 MAbs, except perhaps MAb 10, were directed against epitopes in the region between amino acids 238 and 429. This suggests that this region may be less antigenic in the mouse, or it indicates an incompleteness of our panel of MAbs against gI, or it may be explained by a combination of these factors.
The Pepscan analysis showed that the antigenic domains B and D were continuous whereas domain A was discontinuous (Fig. 4) . The three remaining domains (C, E and F) were not identified by Pepscan analysis. Two antigenic domains (C and E) represented by MAb 2 and by the MAbs 6 and 9, were mapped by immunoscreening of the fusion proteins on plasmid ps2. The MAbs did not react with the fusion proteins of the plasmids ps3 and ps4. This may be explained by the antigenic domain being encoded at the NcoI restriction site, or by a local conformation present in the fusion proteins of plasmid ps2, which is absent in the fusion proteins of plasmids ps3 and ps4 and necessary for the recognition of the MAbs. The presence of a local conformation in the fusion proteins is in agreement with the fact that these MAbs did not react in the Pepscan either.
It is most probable that only conformation-independent epitopes are detected by immunoscreening of prokaryotic fusion proteins (Lenstra et al., 1989) . However small local conformations are likely to be present in the fusion proteins. The same has been found by Lenstra et al. (1989) for a MAb directed against infectious bronchitis virus.
To define antigenic domains C, E and F further, MAbresistant mutants will be selected and sequenced.
MAb 10, representing domain F did not react with pEX expression proteins in a Western blot. However, it reacted in a Western blot with the unglycosylated gI precursor protein and with the glycosylated gI protein (data not shown). This suggests that this MAb represents a conformation-dependent epitope.
In the Pepscan analysis true continuous epitopes usually show a maximum reactivity with one nonapeptide and a decreasing reactivity with the adjacent nonapeptides, as is the case with MAb 7 and MAbs 4, 8 and 11 (Fig. 4a) . The MAbs 1, 3 and 5 reacted in the Pepscan with two peptide regions which were more or less separated (discontinuous epitopes). This suggests a model (Fig. 6) for the secondary structure at this region of the protein. The turns in the protein structure were predicted by the method of Chou & Fasman (1978) .
A noteworthy feature is that these epitopes were mapped by using murine MAbs. In theory the entire surface of a protein is antigenic; however the probability of obtaining antibodies to any given site varies greatly among different animals .
All sera from experimentally infected pigs contained antibodies which react with the fusion protein of the immunodominant region. None reacted with the protein expressed from the pEX plasmid. However when sera from pigs in the field were tested they reacted regularly with the/~-galactosidase protein (our own observations). The difference in reactivity with fl-galactosidase may be explained by the fact that the pigs infected experimentally were specific-pathogen-free. Therefore assays based on the use of MAbs are preferred for detecting pigs with antibodies to gI. Antibody production in pigs against the individual epitopes will be a subject of further study.
